SCA
AMPH icon

Secor Capital Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Secor Capital Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-32,981
Closed -$386K – 530
2015
Q3 		$386K Buy
+32,981
New +$495K 0.12% 287

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Secor Capital Advisors's AMPH Position: Q4 2015 in Review

Secor Capital Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2015, closing a stake of 32,981 shares — an estimated $386K sold.

Secor Capital Advisors first reported a position in AMPH in Q3 2015 and held it in 1 quarter. The position peaked at $386K in Q3 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q4 2015.

  • Secor Capital Advisors reported no remaining Amphastar Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Secor Capital Advisors sold 32,981 Amphastar Pharmaceuticals shares in Q4 2015, an estimated $386K.
  • Secor Capital Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Secor Capital Advisors's Amphastar Pharmaceuticals position peaked at $386K in Q3 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2015.

Based on Secor Capital Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.